List details

Basic info

Status Opinion Adopted
Submitter Germany
Submitter email chemg@baua.bund.de
Regulatory programme
  • Chemical registered under REACH


Proposed harmonised classification by the dossier submitter
  • Resp. Sens. 1, H334
  • Skin Sens. 1A, H317
Hazard classes open for commenting Respiratory sensitisation Skin sensitisation
Proposed specific concentration limits by the dossier submitter Skin Sens. 1A;H317: C ? 0,001 %

Intention timeline

Date of intention 2017-08-04
Expected date of submission 2018-08-31
Submitted for accordance check 2018-08-14
Final submission date 2019-07-12
Start of consultation 2019-08-26
Deadline for commenting 2019-10-25
Date of opinion 2020-09-17
Legal deadline for opinion adoption 2021-01-10


CLH report
Annexes to the CLH Report
Comments received
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
June 1, 2021
  • Background document: https://echa.europa.eu/documents/10162/372c33c4-69ea-95de-e6d6-d025d8f26234https://echa.europa.eu/documents/10162/ef2fd2b9-b60f-8cad-c92c-a0c6832b3ffb
  • Comments received: https://echa.europa.eu/documents/10162/e6fb27d0-a137-5af7-b449-0254938e4120https://echa.europa.eu/documents/10162/f98d19f8-5300-cf34-8901-94c33d9440c6
  • RAC opinion: https://echa.europa.eu/documents/10162/31da8706-a372-6140-e6c8-9e9a803c703fhttps://echa.europa.eu/documents/10162/76efd7f4-895d-2f68-67fb-ad5dcd0d1eb4
April 9, 2021
  • Name: 1,3-Bis-(isokyanatomethyl)benzen1,3-bis(isocyanatomethyl)benzene
March 31, 2021
  • Name: 1,3-bis(isocyanatomethyl)benzene1,3-Bis-(isokyanatomethyl)benzen
Dec. 14, 2020
  • Comments received: https://echa.europa.eu/documents/10162/b0bce314-7602-51aa-5150-0448457de325
Dec. 8, 2020
  • Proposed specific concentration limits by the dossier submitter: Skin Sens. 1A;H317: C ? 0,001 %
  • Status: Opinion DevelopmentOpinion Adopted
Dec. 7, 2020
  • Background document: https://echa.europa.eu/documents/10162/372c33c4-69ea-95de-e6d6-d025d8f26234
  • Comments received: https://echa.europa.eu/documents/10162/e6fb27d0-a137-5af7-b449-0254938e4120
  • RAC opinion: https://echa.europa.eu/documents/10162/31da8706-a372-6140-e6c8-9e9a803c703f
Oct. 29, 2020
  • Date of opinion: 2020-09-17
July 28, 2020
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/10cd7145-f6d9-2a0a-a888-f03c5c785abehttps://echa.europa.eu/documents/10162/fd6599d6-4556-7011-39a5-851762636d5b
  • CLH report: https://echa.europa.eu/documents/10162/752a532b-d554-e21e-2598-31cc866f290fhttps://echa.europa.eu/documents/10162/5bc7a1c0-59bc-a4d6-1f0b-eac344f5f167
  • Comments received: https://echa.europa.eu/documents/10162/129c792f-fb9c-6689-9940-b6d6da37bae1https://echa.europa.eu/documents/10162/b0bce314-7602-51aa-5150-0448457de325
March 12, 2020
  • Submitter email: chemg@baua.bund.de
Nov. 11, 2019
  • Comments received: https://echa.europa.eu/documents/10162/129c792f-fb9c-6689-9940-b6d6da37bae1
Nov. 5, 2019
  • Status: Public ConsultationOpinion Development
Aug. 30, 2019
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/10cd7145-f6d9-2a0a-a888-f03c5c785abe
  • CLH report: https://echa.europa.eu/documents/10162/752a532b-d554-e21e-2598-31cc866f290f
  • Deadline for commenting: 2019-10-25
  • Final submission date: 2019-07-12
  • Hazard classes open for commenting: Respiratory sensitisation Skin sensitisation
  • Legal deadline for opinion adoption: 2021-01-10
  • Status: SubmittedPublic Consultation
  • Start of consultation: 2019-08-26
April 4, 2019
  • Regulatory programme: Other substanceChemical registered under REACH
Add the related substance to your watchlist to monitor this regulatory record.